首页|时空分割在中央型非小细胞肺癌立体定向放射治疗中的应用

时空分割在中央型非小细胞肺癌立体定向放射治疗中的应用

扫码查看
目的:针对中央型肺癌大分割治疗的风险,研究时空分割在中央型非小细胞肺癌(NSCLC)立体定向放射治疗(SBRT)中的应用潜力.方法:选择20例体积较大的中央型NSCLC患者进行回顾性分析,为每位患者设计SBRT计划和时空分割计划,采用剂量体积直方图和剂量统计学参数等方法对两种治疗方案进行比较和评估.结果:时空分割在保证计划靶区(PTV)剂量与SBRT相当的前提下,显著降低了正常器官的物理剂量和生物等效剂量EQD10,其中肺、脊髓、心脏、气管和主支气管、食管的物理剂量分别降低了(11.16±0.37)%、(10.5±1.42)%、(16.6±0.49)%、(18.28±0.55)%、(18.58±1.34)%,EQD10 分别降低了(13.44±0.34)%、(10.03±1.44)%、(11.93±0.52)%、(22.26±0.52)%和(25.5±1.23)%.结论:与SBRT相比,时空分割能够在确保肿瘤控制的同时,更有效地减少周围正常组织的受损程度,提高了中央型NSCLC大分割治疗的安全性和有效性.
Application of spatiotemporal fractionation in stereotactic body radiation therapy for central non-small cell lung cancer
Objective:To explore the application potential of spatiotemporal fractionation in stereotactic body radiation therapy(SBRT)for central non-small cell lung cancer(NSCLC)due to the risks associ-ated with large fractionations.Methods:Twenty patients with centrally located NSCLC and large tu-mor volumes were retrospectively analyzed.SBRT plans and spatiotemporal fractionation plans were designed for each patient,and the two treatment strategies were compared and evaluated using dose-volume histograms and dose statistics parameters.Results:Spatiotemporal fractionation significantly reduced the physical doses and equieffective dose EQD10 of normal organs while ensuring plan target volume(PTV)doses equivalent to SBRT.The physical doses of the lungs,spinal cord,heart,tra-chea/main bronchi,and esophagus were reduced by(11.16±0.37)%,(10.5±1.42)%,(16.6±0.49)%,(18.28±0.55)%,(18.58±1.34)%,respectively,and EQD10 values were reduced by(13.44±0.34)%,(10.03±1.44)%,(11.93±0.52)%,(22.26±0.52)%,and(25.5±1.23)%,re-spectively.Conclusion:Compared with SBRT,spatiotemporal fractionation can effectively reduce the damage to surrounding normal tissues while ensuring tumor control,thus improving the safety and effectiveness of large fractionation treatment for centrally located NSCLC.

Central Non-Small Cell Lung CancerSpatiotemporal FractionationStereotactic Body Radiation TherapyPhysical DoseBiological Equivalent DoseDose-Volume HistogramSafety

陈诚、沈九零、蒋大振、刘晖

展开 >

武汉大学中南医院肿瘤放射治疗中心 湖北 武汉 430071

中央型非小细胞肺癌 时空分割 立体定向放射治疗 物理剂量 生物等效剂量 剂量体积直方图 安全性

2024

武汉大学学报(医学版)
武汉大学

武汉大学学报(医学版)

CSTPCD
影响因子:0.959
ISSN:1671-8852
年,卷(期):2024.45(11)